Hussman Strategic Advisors Inc. Purchases 126,000 Shares of Pediatrix Medical Group, Inc. $MD

by · The Markets Daily

Hussman Strategic Advisors Inc. raised its position in Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) by 150.0% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 210,000 shares of the company’s stock after purchasing an additional 126,000 shares during the period. Hussman Strategic Advisors Inc.’s holdings in Pediatrix Medical Group were worth $3,014,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently added to or reduced their stakes in the company. Wakefield Asset Management LLLP bought a new stake in shares of Pediatrix Medical Group in the second quarter valued at about $1,002,000. Atria Investments Inc increased its position in Pediatrix Medical Group by 9.4% during the second quarter. Atria Investments Inc now owns 16,435 shares of the company’s stock worth $236,000 after acquiring an additional 1,411 shares during the period. Keybank National Association OH acquired a new stake in Pediatrix Medical Group in the 2nd quarter worth about $226,000. Freedom Investment Management Inc. bought a new stake in Pediatrix Medical Group in the 2nd quarter valued at about $151,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Pediatrix Medical Group in the 2nd quarter valued at about $1,033,000. Institutional investors own 97.71% of the company’s stock.

Analyst Upgrades and Downgrades

MD has been the topic of several recent research reports. Leerink Partners raised their target price on shares of Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a “market perform” rating in a report on Friday, September 5th. Weiss Ratings reissued a “hold (c)” rating on shares of Pediatrix Medical Group in a research report on Wednesday, October 8th. Zacks Research lowered Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 7th. UBS Group lifted their price objective on Pediatrix Medical Group from $16.00 to $16.50 and gave the company a “neutral” rating in a report on Thursday, August 14th. Finally, Truist Financial set a $17.00 target price on Pediatrix Medical Group in a research report on Tuesday, October 14th. Two analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $17.25.

Get Our Latest Stock Report on Pediatrix Medical Group

Pediatrix Medical Group Stock Up 24.6%

Shares of MD opened at $21.14 on Tuesday. The firm has a 50 day simple moving average of $16.92 and a two-hundred day simple moving average of $14.89. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.80 and a quick ratio of 1.80. Pediatrix Medical Group, Inc. has a one year low of $11.84 and a one year high of $21.24. The company has a market cap of $1.84 billion, a P/E ratio of 16.39 and a beta of 1.26.

Pediatrix Medical Group (NYSE:MD – Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, topping analysts’ consensus estimates of $0.42 by $0.11. The firm had revenue of $468.84 million during the quarter, compared to analysts’ expectations of $464.37 million. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The business’s revenue for the quarter was down 7.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.34 earnings per share. Research analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Pediatrix Medical Group Company Profile

(Free Report)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Featured Stories

Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD – Free Report).